NCCN Guidelines® Updates: Management of Muscle-Invasive Bladder Cancer
Recent implementation of the 8th edition of the AJCC Cancer Staging Manual prompted an overhaul of the treatment algorithms for muscle-invasive bladder cancer in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Bladder Cancer.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Novel Treatment Options for Neuroendocrine Tumors
There are now multiple approved treatments and several promising trials with different agents, including some directed therapies, for patients with neuroendocrine tumors (NETs). The sequencing of these treatments is controversial and will become more complicated as further drugs are approved.
Category
  • Neuroendocrine Tumors
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Mutation Testing and Adjuvant Systemic Therapy in Cutaneous Melanoma
Several new adjuvant systemic therapy options for adjuvant treatment of stage III melanoma were added to the melanoma guidelines in v2018, such that there are now multiple adjuvant systemic therapy options in some settings.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Developments in Systemic Therapy for Soft-tissue and Bone Sarcomas
Due to the rare nature of these malignancies, many clinicians have limited experience in treating patients with sarcoma.
Category
  • Soft Tissue Sarcomas
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Biomarker Testing for Immunotherapy
Recommendations and requirements for biomarker testing vary by the type of immune checkpoint inhibitor (ICI), specific tumor characteristics, and treatment setting.
Category
  • Bladder Cancer
  • Colorectal Cancer
  • Gynecologic Cancers
  • Kidney Cancer
  • Lung Cancers
  • Melanoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Acute Myeloid Leukemia
Novel and Emerging Treatment Options for Acute Myeloid Leukemia
Category
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Colorectal Cancer
Emerging Approaches to Personalized Medicine in Colorectal Cancer
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma
Management of Multiple Myeloma
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Survivorship, Version 2.2019
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for consequences of cancer and cancer treatment to aid healthcare professionals who work with survivors of adult-onset cancer.
Category
  • Survivorship
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Evidence-based Strategies for the Management of Central Venous Catheters
Central venous catheters (CVCs) are an important component of cancer treatment and require multidisciplinary care due to significant complications associated with vascular access devices.
Category
  • Palliative Care
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation

Pages